DocGo Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)
DocGo Inc. (DCGO) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $168 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-08-17
- DocGo Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-06-30 was $168.00, a 61.38% decline year-over-year.
- DocGo Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-03-31 was $7.11K.
- DocGo Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-12-31 was $41.48K.
- DocGo Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-09-30 was $8.10K.
- DocGo Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $50.01K.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $168.00 10-Q · filed 2026-08-17 | $7.28K 10-Q · filed 2026-08-17 | $48.76K derived: sum of 3 quarters · filed 2026-08-17 | $56.85K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $7.11K 10-Q · filed 2026-05-11 | $48.59K derived: sum of 2 quarters · filed 2026-05-11 | $56.69K derived: sum of 3 quarters · filed 2026-05-11 | $57.12K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $41.48K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $49.57K derived: sum of 2 quarters · filed 2026-03-16 | $50.01K derived: sum of 3 quarters · filed 2026-08-17 | $50.01K 10-K · filed 2026-03-16 |
| 2025-09-30 | $8.10K 10-Q · filed 2025-11-10 | $8.53K derived: sum of 2 quarters · filed 2026-08-17 | $8.53K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $435.00 10-Q · filed 2026-08-17 | $435.00 10-Q · filed 2026-08-17 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |